InsidersTradesSigma
Follow the 삼천당제약 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 삼천당제약 has recorded 2 reports. Market capitalisation: €6,121.1bn. The latest transaction was filed on 6 April 2026 (Mixed). Among the most active insiders: 전인석. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.